CSG's Balance-Sheet Squeeze: The Real Story Behind a Defence Giant's Falling Share Price

CSG's shares drop 54% from January high despite strong orders and expansion; analysts split on outlook as working capital weighs.

Investors scanning CSG's share price might assume the Czech defence group is struggling. The stock closed Friday at €16.61, down 2.5 percent on the day and 8.4 percent lower over seven trading sessions. Yet the company's operational narrative tells a very different story — one of relentless expansion, a bulging order book and strategic bets stretching from German explosives production to Canadian hypersonics.

The disconnect between CSG's corporate momentum and its market performance has become the defining puzzle for shareholders. Since hitting a 52-week high of €36.05 in late January, the shares have shed 54 percent of their value. Technical indicators offer little comfort: the stock trades within 0.1 percent of its 50-day moving average of €16.59, while the relative strength index of 40.1 points to weak but not oversold conditions.

A Spending Spree Across Three Continents

The past few weeks have brought a steady stream of announcements. CSG acquired the Gnaschwitz industrial site in Germany for nitroglycerin production, deepened its partnership with Ukrainian firm Ukrainian Armor on propulsion systems for rockets and unmanned platforms, and took a strategic minority stake in Canadian technology company North Vector Dynamics, which focuses on air defence, precision-guided missiles and hypersonic technologies. A US joint venture for turbojet and turbofan engines for drones rounds out the picture.

The pattern is clear: CSG is transforming itself from a land systems and ammunition manufacturer into a vertically integrated defence player with in-house propulsion and sensor capabilities. The company also announced a roughly €49.7 million investment over three years to expand military ground systems production at Tatra Defence in Kop?ivnice, adding 14,000 square metres of new manufacturing space.

The order flow has been equally brisk. Late August brought contracts worth more than $50 million for bridge-laying vehicles with customers in Europe, the Middle East and Southeast Asia. Mid-August saw CSG sign deals exceeding €150 million with Polish defence group Huta Stalowa Wola for several hundred tactical vehicle chassis, plus a €100 million ammunition components contract with Polish firm Dezamet.

Why Cash Is Tied Up

The first-half numbers justify the expansion drive. Revenue climbed 17.2 percent to €3,251 million, operating EBIT grew 12.7 percent, and the margin of 24.1 percent landed within the company's own guidance. The Defence Systems division stood out with 27.0 percent revenue growth. The order backlog reached €17 billion, and combined with the pipeline, totals €46 billion — up from €44 billion in March. Land Systems now accounts for 46 percent of the backlog.

But there is a cost to this growth. Net working capital stands at €2.9 billion, equivalent to 40 percent of revenue, driven by strategic stockpiling of materials. Management expects this capital to be released in the second half of the year. The company has also refinanced its credit facilities, cutting borrowing costs by 125 to 150 basis points and extending maturities to six years. Net debt currently sits at 1.6 times EBITDA, though CSG expects that ratio to fall below 1.3 times by year-end.

Analysts Split on the Outlook

The mixed analyst reaction to the half-year results captures the uncertainty. Barclays expressed scepticism in mid-August, while RBC Capital Markets upgraded the stock to Neutral with a Sector Perform rating, citing a favourable ammunition market environment. Berenberg raised its forecasts after the results but simultaneously cut its price target.

Fitch, meanwhile, confirmed CSG's credit rating on Wednesday with a stable outlook, pointing to the group's dominant market position. The endorsement came as CSG companies showcased new defence products at the MSPO trade fair in Kielce in early September.

For the 2026 fiscal year, CSG reaffirmed its guidance: revenue between €7.4 billion and €7.6 billion, with an EBIT margin of 24 to 25 percent. Investors will get their next major checkpoint on November 11, when the company reports full-year results. By then, the question of whether the promised release of working capital materialises — and whether the new international partnerships translate into operational gains — should become clearer. For now, the market appears to be weighing CSG's heavy investment phase against its undeniably strong underlying demand.